Clinical Trials in Nagoya Shi, Aichi

A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

NCT ID: NCT05029895

This clinical trial is looking at the safety and effectiveness of a medication called upadacitinib for treating atopic dermatitis (AD), a skin condition that causes inflammation and itching. The st...

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

NCT ID: NCT06158854

This clinical trial is studying a new treatment called ABBV-383 for adults with a condition known as immunoglobulin light chain (AL) amyloidosis. AL amyloidosis happens when certain proteins build ...

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT ID: NCT05259839

This clinical trial is studying the safety and effectiveness of a new drug called ABBV-383 when given together with other treatments for adults with relapsed or refractory multiple myeloma, a type ...

Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

NCT ID: NCT04340115

This clinical trial is designed to study how often serious infections occur in adults with rheumatoid arthritis (RA) who are taking the medication RINVOQ. RA is a long-lasting condition that causes...

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

NCT ID: NCT04862286